Invest Knowledge Media – Investing and Stock News

Invest Knowledge Media – Investing and Stock News
— Read on investknowledgemedia.com/

Gold Alert: Extraordinary Upside in One Stock (Not a…

 Focused market insights, strategic perspectives, and actionable ideas for informed investors.Gold Alert: Extraordinary Upside in One Stock (Not a Miner) – Ad

Gold has hit all-time highs, breaking $4,000 an ounce – but history shows it could be on the verge of its biggest bull run in over half a century… triggered by a likely major event, eerily similar to what happened in the 1970s. (It’s NOT inflation or anything you’re likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk. See this immediately.Trump Announced New ‘Golden Fleet’ Battleships Named After Himself. Then This Stock Popped— Here’s Why

Shares of this South Korean shipbuilder climbed sharply on Tuesday, after President Donald Trump said the company will be involved in constructing a new class of warships for the U.S. Navy. More Info ➔The Market Just Crossed a Dangerous Line – Ad

The man who predicted the 2008 crash and 2020 says today’s soaring markets are NOT a bubble – they’re something far stranger and more dangerous. He says it’s about to change everything you know about money. Full story here.Bill Ackman Warns California Is ‘On A Path To Self-Destruction’ As Larry Page, Peter Thiel Weigh Exiting State Over Proposed Billionaire Wealth Tax

Bill Ackman warned that California is driving itself toward economic decline amid a proposed billionaire wealth tax prompts. More Info ➔Congressman Discloses 50+ Stock Trades: Here’s Why Purchasing Palantir Stock Is Catching Attention

A member in Congress recently disclosed over 50 stock transactions. The trade in Palantir Technologies might stand out and not because of its 2025 gains. More Info ➔The Tesla Shock Nobody Sees Coming – Ad

While headlines scream “Tesla is doomed”…Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla’s labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29. See the Tesla shock that could blindside everyone.California delays revoking 17,000 commercial driver’s licenses until March after immigrants sue

A week after immigrant groups , California said Tuesday it will delay the commercial driver’s licenses until March to allow more time to ensure that truckers and bus drivers who legally qualify for the licenses can keep them. More Info ➔FBI Charges Visa-Holding Researcher With Smuggling E. Coli Into US: ‘Please Be Vigilant Of This Trend,’ Says Kash Patel

The FBI charged a visa-holding postdoctoral researcher with allegedly smuggling E. coli from China into the U.S. and lying to authorities, as Director Kash Patel warned universities to tighten oversight amid broader biosecurity and immigration enforcement. More Info ➔AI Created by Fmr. Nuclear Missile Coder Issues Urgent Projection for Nvidia Holders – Ad

A former lieutenant colonel who worked on top secret tech for the military has now released an AI that can foresee U.S. stock prices up to 21 days in advance. What it says about Nvidia could soon affect the entire U.S. market. Click here to see this AI’s latest projection for free.Silver Jumps 6%, Platinum Up 8%, Palladium Up 11% As Metal Shock Erupts: What’s Moving Markets Friday?

While Wall Street traded in a subdued session marked by thin liquidity and low volumes following the Christmas market closure, price action turned wild across precious and industrial metals. More Info ➔Noem and Kash Under Scrutiny As Year Closes

DHS Secretary Noem and FBI Director Patel are facing mounting scrutiny. This has led to speculation about their future in their current roles. More Info ➔50-year Wall Street Veteran Names Top Stock of 2026 – Ad

A top Wall Street strategist just named his #1 stock for 2026. His system hits 8 of the top 10 stocks each year, and his last picks surged 100% and 160%. Now he says this new ticker could double in 12 months. He’s revealing it free on camera. To hear it for yourself 100% free, go here.5 Stocks to Sell as Homebuilder Slump Deepens

Avoid Lennar Corp. and Meritage Homes Corp. as the housing market continues to suffer due to high rates, labor shortage, and tariffs on materials. More Info ➔Cathie Wood Dumps $11 Milllion Worth Of Tesla Stock While Doubling Down On These Notable Crypto Plays

On Thursday, Cathie Wood-led Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc. More Info ➔3 Small AI Plays to Buy for 2026

Wall Street ends 2026 positively with tech stocks dominating, but concerns over valuations drive interest in smaller AI stocks for 2026. More Info ➔Walmart Founder Sam Walton’s Genius Move: Why He Never Gave His 5 Kids Company Stock

Sam Walton’s estate planning kept his Walmart stock in a trust, protecting it from divorce courts. This strategy was key to preserving family wealth. More Info ➔5 Stocks to Sell as Bitcoin Tumbles

As 2025 comes to a close, most assets have seen gains. However, cryptocurrencies have not participated. Here are 5 stocks to avoid if Bitcoin drops. More Info ➔Buffett’s Big Insurance Bet Rakes In $830 Million Since September (CORRECTED)

Berkshire Hathaway increased its position in four stocks in the third quarter. One of those bets is paying off nicely with the total stake up $830 million since Q3. More Info ➔

Information, charts, or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising and partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted into our newsletter.

If you wish to no longer receive these offers, click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons, we strongly suggest trading in a DEMO/Simulated account.

The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices, or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct, or truthful.

If you use, act upon, or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates, and agents without fault.

2967 Dundas St. W. #990, Toronto, ON M6P 1Z2 | Phone Number: 917.672.7040

© 2025 Musth | MarketHundred | All rights reserved. 
UNSUBSCRIBE

God Of Income – God Of Income – Investing…

God Of Income – God Of Income – Investing and Stock News
— Read on godofincome.com/

Old American Broker – Investing and Stock News

Old American Broker – Investing and Stock News
— Read on oldamericanbroker.com/

US Lucrative News – Investing and Stock News

US Lucrative News – Investing and Stock News
— Read on uslucrativenews.com/

Finance Next Steps

Finance Next Steps
— Read on financenextsteps.com/

Welcome! Your Top 7 Basic Materials Stocks Report Has…

Welcome to FinStrategist! Your is ready below.

You will also start getting our daily newsletter that will keep you updated on important market news in less than 5 minutes. Each newsletter will cover:

• Market Drivers: Key business and stock headlines moving the tape.
• Breakout Finds: Stock reports on tickers with upside potential.
• Investing Ideas: Fresh opportunities from our partner network.

To access the report you just downloaded, click on the link below.Open Your Report

P.S. Reply with a quick ‘hey’ so we stay out of spam. To keep us in your inbox, use these whitelisting steps.

---

Information, charts, or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising and partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted into our newsletter.

If you wish to no longer receive these offers, click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons, we strongly suggest trading in a DEMO/Simulated account.

The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices, or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct, or truthful.

If you use, act upon, or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates, and agents without fault.

2967 Dundas St. W. #990, Toronto, ON M6P 1Z2 | Phone Number: 917.672.7040

© 2025 Musth | FinStrategist | All rights reserved. 
UNSUBSCRIBE

Before You Sleep: Pull Up (INBS)—See Why It’s Topping…

Any content you receive is for information purposes only. Always conduct your own research.

*Sponsored

Krypton Street Puts (INBS) On The Watchlist For Tomorrow Morning —Wednesday, December 31, 2025

Full Coverage Will Start Early 

Don’t Miss The Next Breakout—Get Real-Time Alerts Sent Directly 

To Your Phone. Up To 10X Faster Than Email.

Pull Up (INBS) Before Tomorrow Morning…

December 30, 2025

Before You Sleep | Pull Up (INBS)—See Why It’s Topping Tomorrow’s Watchlist

Dear Reader,

The biggest stories don’t always start with the loudest headlines—they often begin quietly, in corners of the market most people aren’t watching.

But when real momentum starts building, the early signals tend to show up first… long before the wider crowd catches on.

And tonight, one of those signals is starting to stand out.

That’s why (INBS) is back on our radar heading into the final day of 2025.

Intelligent Bio Solutions Inc. (Nasdaq: INBS) is a medical technology company focused on a faster, simpler way to screen for dru-g use.

Instead of urine or saliva tests, its system uses a fingerprint and a small amount of sweat to deliver results in under 10 minutes—without invasive procedures or specialized facilities.

Earlier this month, the company completed a 1-for-10 reverse split, leaving it with a razor-thin float, with fewer than 900K shares listed as available to the public. When companies have small floats like this, the potential exists for big swings if demand begins to shift.

And that’s just one of the reasons why (INBS) will be topping our watchlist tomorrow morning—Wednesday, December 31, 2025.

And we’re not the only ones taking a closer look.

In a report published today, December 30, Ladenburg Thalmann analyst Jeffrey S. Cohen maintains a $12.00 target, suggesting over 170% upside potential from recent levels.

As the business continues to expand commercially, that structure can magnify the impact of new developments.

The company is also showing clear signs of progress.

For Q1 FY2026, the company recently announced record revenue levels,marking the third straight quarter of growth.

Margins strengthened, and recurring sales from consumable testing cartridges now make up more than half of total revenue.

Today, (INBS) serves over 480 active customers across 27 countries, with more than 1,700 testing readers already in the field.

Several key developments are now lining up.

New Strategic Partnership Expands Wearable Health Monitoring Reach

On December 18, 2025, Intelligent Bio Solutions announced a non-exclusive strategic partnership with Vlepis, an Australian medical and wellbeing technology company specializing in advanced sensing and wearable patch technologies.

The collaboration is designed to support joint research and development efforts, expand distribution capabilities, and leverage regulatory expertise to accelerate international adoption of non-invasive testing and monitoring solutions.

Vlepis’ wearable technologies and software platforms complement INBS’ existing portfolio, which includes its fingerprint-based screening system and the SmarTest® monitoring patch.

The partnership gives INBS the ability to evaluate connected wearable devices, cloud-based platforms, and mobile health applications that could extend its product ecosystem beyond traditional screening environments.

This collaboration also positions INBS to participate in the rapidly expanding wearable medical devices market, valued at approximately $42.7B in 2024 and projected to grow at an annual rate exceeding 25% through 2030—supporting a broader push into business-to-business, business-to-consumer, and consumer health monitoring settings.

Alongside this partnership, other developments remain in focus, including progress toward FDA 510(k) clearance in the U.S., continued international customer growth, the rollout of a continuous monitoring patch, and improving efficiency as recurring consumable sales increase.

At the same time, the global dr-ug screening market is expanding rapidly, projected to grow roughly 270%—from about $10.55B in 2025 to nearly $39.32B by 2034.

Within this growing landscape, (INBS)differentiates itself through faster results, simpler deployment, and lower overall testing costs compared to traditional methods.

As key regulatory and commercial milestones draw closer, the company’s unusually small share structure adds an extra layer of focus on what unfolds next.

Company Overview

Founded in 2016, Intelligent Bio Solutions develops non-invasive dr-ug testing through proprietary fingerprint sweat analysis. The idea behind the company’s approach is simple: make dr-ug screening faster, easier, and less intrusive than traditional methods. Instead of relying on samples that require special handling or long wait times, the company designed a system that fits seamlessly into real-world settings.

How the Technology Works

(INBS)’s core testing system uses a fingerprint to screen for recent dr-ug use. Instead of providing a urine or saliva sample, a person simply places a fingertip on a small cartridge for about five seconds. That cartridge is then inserted into a handheld reader, which delivers results in under 10 minutes.

The system is designed to identify recent use of substances such as opiates, co-ca-ine, me-thamp-heta-mine, can-nab-is, and ben-zo-di-azep-ines. Because it analyzes sweat from the fingerprint, it focuses on recent activity—typically within the past 16 to 24 hours—rather than detecting older history.

Why It’s Different from Traditional Tests

Compared with urine or saliva testing, this approach is faster, simpler, and easier to deploy. Results are available in minutes instead of hours, the process is non-invasive, and testing can be done on-site without the need for specialized facilities. On an annual basis, the overall cost is also lower than many traditional testing methods.

SmarTest® Continuous Monitoring Patch

In addition to fingerprint testing, the company has introduced the SmarTest® Patch, a wearable device designed for longer-term monitoring. The patch collects sweat over a 7 to 10 day period and can detect substances such as fen-tan-yl, co-ca-ine, and opiates. This product was launched in Q1 FY2026 and opens the door to use cases that require ongoing observation rather than one-time screening.

Customer Base and Target Markets

Current Deployment (480+ Active Accounts): Safety-critical industries including construction, manufacturing, transportation/logistics, mining, maritime, electrical/electronic manufacturing, dr-ug treatment organizations, corrections facilities, government administration.

Geographic Distribution: UK (strongest growth market), Europe, Middle East, Asia Pacific. Currently operates primarily outside the U.S. under Forensic Use Only designation domestically.

Target Expansion Markets:

• Government: Border security, customs, defense, state agencies, emergency responders
• Law Enforcement/Corrections:Roadside testing, probation/parole monitoring, court-mandated programs
• Workplace: Expanding beyond current safety-critical focus into broader corporate testing

U.S. Market Potential: Over 70% of those abusing dru-gs in the U.S. are employed.

Dru-g test positivity post-accident has climbed over the past five years.

Global dr-ug screening market value is expected to top $39B within the next decade.

FDA 510(k) Clearance: Gateway to U.S. Market

(INBS) advancing toward FDA 510(k) clearance in H2 2026—unlocking the massive U.S. workplace dr-ug testing market.

Progress (September 2025 Update):Initial 510(k) submitted December 2024. FDA engaged with 70+ item Additional Information requests (standard process). The company submitted responses in August 2025.

Proactively initiating additional clinical studies (complete H1 2026). FDA clearance on track for H2 2026.

Over 70% of U.S. substance abusers are employed. dr-ug test positivity post-accident rising.

INBS’s superior technology (faster, cheaper, non-invasive, recent impairment focus) positioned to capture market share from legacy urine/saliva once approved.

Strategic Advantage: Unlike competitors with unproven technology, INBS brings 1,700+ deployed readersand 480+ customer relationshipsdemonstrating real-world validation.

FDA clearance could convert international success into an immediate U.S. market.

Major Upcoming Potential Catalysts

• FDA 510(k) Clearance (H2 2026):Unlocks massive U.S. workplace market. 1,700+ international readers prove technology—FDA clearance converts global success into a domestic opp.
• Customer Acceleration: Added 33 accounts Q1 (50% YoY growth). Network effects from early adopters drive accelerating additions.
• Margin Expansion: Consumable mix 57.6% (up from 51.1%) with higher margins. Gross margins expanding toward 50%+ with a clear pro-fit-ability pathway.
• SmarTest Patch: Continuous 7-10 day monitoring opens new markets—probation/parole, rehabilitation, clinical trials, workplace monitoring.
• Distribution Expansion: SMARTOX partnership plus 18 distributors create global infrastructure. Geographic expansion (Middle East, Asia Pacific) accelerating with minimal capital.
• Enterprise Deployments: 4,400-staff UK provider and 14-site London transport validate large-scale capability—opening Fortune 500 pipeline post-FDA.

7 Reasons Why (INBS) Will Be Topping Our Watchlist Tomorrow Morning —Wednesday, December 31, 2025.

1. Tiny Float: with fewer than 900K shares listed as available to the public, (INBS)’s small float could witness the potential for big moves if demand begins to shift.

2. Analyst Coverage: following a December 30 report highlighting a $12 target that suggests over 170% upside potential, (INBS) has added third-party attention to an already developing story.

3. Real Adoption: with well over 480 active customers across 27 countries, (INBS) is already showing real-world usage rather than early-stage testing.

4. Recurring Sales: with consumable cartridges now making up more than half of total revenue, (INBS) is seeing repeat activity tied to its installed base.

5. Record Quarter: after reporting $1.11M in Q1 FY2026 revenue and three straight periods of growth, (INBS) is showing measurable commercial progress.

6. Wearable Expansion: after announcing a strategic partnership with Vlepis, (INBS) is positioning its platform for consumer health monitoring alongside commercial screening.

7. Big Market Tailwinds: with the global screening industry projected to grow roughly 270% from $10.55B in 2025 to $39.32B by 2034, (INBS) is operating inside a rapidly expanding landscape.

Pull Up (INBS) Before Tomorrow Morning…

When you step back and look at the full picture, (INBS) checks several boxes that tend to pull serious attention. The share structure is razor-thin, recent analyst coverage has added a new layer of visibility, and real-world adoption is already in place across hundreds of customers internationally.

Add in a rising base of repeat cartridge sales, a record quarter that marked three straight periods of growth, and a fresh push into wearable health monitoring—and it’s easy to see why this story is building momentum heading into year-end.

With global screening demand projected to expand sharply over the next decade, (INBS) is operating in a landscape that’s getting bigger—and moving faster.

We will have all eyes on (INBS) tomorrow morning.

Take a look at (INBS) before you call it a night.

Also, keep a lookout for my morning update.

Have a good night.

Sincerely,

Alex Ramsay
Co-Founder / Managing Editor
Krypton Street Newsletter

KryptonStreet.com (“KryptonStreet” or “KS” ) is owned by Media 1717 LLC, a single member limited liability company. Data is provided from third-party sources and KS is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile KS brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.

Pursuant to an agreement between Media 1717 LLC and TD Media LLC, Media 1717 LLC has been hired for a period beginning on 12/30/2025 and ending on 12/31/2025 to publicly disseminate information about (INBS:US) via digital communications. Under this agreement, Media 1717 LLC has been paid six thousand USD (“Funds”). To date, including under the previously described agreement, Media 1717 LLC has been paid sixteen thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from a third party who did receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.

Neither Media 1717 LLC, TD Media LLC and their member own shares of (INBS:US).

Please see important disclosure information here: https://kryptonstreet.com/disclosure/inbs-zVO5H/#detailsMedia 1717 LLC6586 W Atlantic AveUnit #2086Delray Beach, FL 33446UnsubscribeUpdate Profile | Constant Contact Data NoticeSent by alex@kryptonstreet.com

Why smart money sits still (act now)

Gianni Di Poce has precious metal positions that are decades old.

Massive ETF positions just sitting in accounts he never touches. Compounding quietly. Growing relentlessly.

This is what happens when you understand the fundamental difference between trading and investing—and possess the wisdom to know when each approach serves you best.

Gianni grasps something that eludes most market participants: “Not every pullback or not every market that is going down has to mean a global financial crisis, guys.”

This sophisticated perspective emerges from years of watching markets breathe through their natural cycles. Up, down, sideways. Panic, euphoria, boredom. The endless rhythm that creates opportunity for those positioned to capture it.

What elevates Gianni’s approach beyond amateur speculation is his ability to be patient with decades-old positions while remaining tactical with shorter-term moves. He reads institutional flow, understands where big money positions itself, and maintains the discipline to act on that intelligence.

“You are not smarter than the market we are here to position,” he reminds us. Success isn’t about predicting—it’s about positioning.

Intelligent positioning demands institutional flow intelligence. The kind Brandon Chapman has been analyzing for 18 years. The kind that reveals where smart money moves before retail investors notice.

Every week, Brandon identifies one crystal-clear signal from institutional flow data. Not a dozen confusing alerts. Not an overwhelming information dump. One actionable insight derived from unusual options activity and professional order flow analysis.

This is the same intelligence that enables traders like Gianni to maintain strategic, long-term perspective while capitalizing on shorter-term opportunities. It’s about accessing the right information at precisely the right moment.

When you can see where institutional money flows, you don’t need to guess whether this pullback represents “the big one” or just another positioning opportunity. You respond based on what smart money actually does, not what headlines scream.

That’s the edge. That’s what Ghost Prints Weekly delivers every single week.

Get Brandon’s weekly institutional flow signal here.

Your edge,
Don Kaufman
Chief Market Strategist

P.S. The difference between successful long-term positioning and short-term tactical moves isn’t luck—it’s having access to the same institutional flow data that professionals use. Start seeing what the smart money sees.

Disclaimer: Neither TheoTrade or any of its officers, directors, employees, other personnel, representatives, agents or independent contractors is, in such capacities, a licensed financial adviser, registered investment adviser, registered broker-dealer or FINRA|SIPC|NFA-member firm. TheoTrade does not provide investment or financial advice or make investment recommendations. TheoTrade is not in the business of transacting trades, nor does TheoTrade agree to direct your brokerage accounts or give trading advice tailored to your particular situation. Nothing contained in our content constitutes a solicitation, recommendation, promotion, or endorsement of any particular security, other investment product, transaction or investment. Trading Futures, Options on Futures, and retail off-exchange foreign currency transactions involves substantial risk of loss and is not suitable for all investors. You should carefully consider whether trading is suitable for you in light of your circumstances, knowledge, and financial resources. You may lose all or more of your initial investment. Opinions, market data, and recommendations are subject to change at any time. Past Performance is not necessarily indicative of future results.

WARNING: If you UNSUBSCRIBE, you will be removed from ALL email lists, including any paid subscription emails. To opt out of this list only and keep other access, forward this email to support@theotrade.com and say “remove me from this particular email list.” Unsubscribe

TheoTrade
16427 N Scottsdale Rd
Suite # 410
Scottsdale, Arizona 85254
United States
1 (800) 256-8876

This TSLA Butterfly Spread Didn’t Quite Hit All-Time Highs

“Sometimes a chart won’t reach all-time highs, and yet I still consider it a successful trade.”

Nate Bear, Lead Technical Tactician, Monument Traders Alliance 

I had mentioned Tesla as a trade idea in the watchlistbefore Christmas.

The chart looked ready to rip, and I got positioned believing it could break over $500 for new all-time highs.

So far that hasn’t happened… not yet anyway.

In late December, it touched $498.83, just shy of the $500.

For my specific trade strategy, I was in a butterfly spread that made my risk-reward ratio almost nothing.

I was risking $19 to make $1,900.

Even though TSLA didn’t hit the ATH, it still had moved up around 180%.

Then… it backed off a little.

That’s when I closed for a 175% gain.

So despite not getting the 200% move I wanted, I still consider TSLA a successful trade.

Overall, I still believe TSLA is going to break over $500, and I’ll be keeping it on my radar early into next year.

Right now it has several catalysts working in its favor…

For one, the Ai robotaxi potential has analysts driving its price up.

Plus, the company is also due to report earnings in January. So any announcement of robotaxi could be a catalyst.

Overall, I believe it’s a manifest destiny thing at this point.

SPONSORED

Not a Single “Mag 7” on This Legendary Investors List

A renowned former hedge fund manager – friends to some of the biggest investors in the world – just released a new list of his favorite AI stocks… and not a single Magnificent 7 name made the cut.

Instead, an AI stock you’ve likely never heard of just flagged as “near-perfect” in his new investing scoring system.

For the name, ticker and demo, click here.

Action Plan: TSLA is just one tech stock I’m watching for a potential trade heading into 2026.

I also recently alerted my Profit Surge Trader members to a historic wealth building event I’m calling “Operation Motherlode.”

This is President Trump’s “brute-force countermeasure” against China’s recent trade threats, and its ripple effects could lead to 28 opportunities for quick triple-digit gains.

Click here to learn more about “Operation Motherlode.”

SPONSORED

Trump’s Favorite AI Energy Stock??

It’s wildly profitable – Over $3 billion in operating income. It has a partnership with the hottest AI stock on Wall Street.

And Trump has publicly backed it? Get the details on #1 AI energy stock here.

Monument Traders Alliance, LLC

You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist.
To unsubscribe from Trade of the Day Wake-Up Watchlist, click here.

Questions? Check out our FAQs. Trying to reach us? Contact us here.
Please do not reply to this email as it goes to an unmonitored inbox.

To cancel by mail or for any other subscription issues, write us at:
Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201

North America: 800.507.1399 | International: +1.443.353.4977
Website | Privacy Policy
Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day.

© 2025 Monument Traders Alliance, LLC | All Rights Reserved

Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation.

Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.

REF: 000142349377